DevalDineshJoshiMD

Ophthalmology • Boynton Beach, FL

Cataract Related, Glaucoma Related, Retinal Disease

Physician

Join to view full profile

Dr. Joshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Joshi's full profile

Already have an account?

Office
10075 S Jog Rd
Suite 203
Boynton Beach, FL 33437
Phone+1 561-767-9999

Fax+1 855-699-3535

Education & Training

University of South Florida MorsaniResidency, Ophthalmology, 2007 - 2010
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2006 - 2007
St. George's University School of MedicineClass of 2006

Certifications & Licensure

FL State Medical License 2011 - 2026
VA State Medical License 2008 - 2012
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

26 citations
Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid
Sheena Bhalla, Deval D. Joshi, Shaminder S. Bhullar, Daniel Kasuga, Yeonhee Park
The British Journal of Ophthalmology. 2013-07-01
51 citations
Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.
Persis S. Bandari, Jing Qian, Ghassan Yehia, Deval D Joshi, Paul Maloof
Regulatory Peptides. 2003-03-28
10 citations
Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P.
Pranela Rameshwar, Pedro Gascon, Persis S. Bandari, Deval D Joshi, Annemarie Fernandes
Canadian Journal of Physiology and Pharmacology. 2002-05-01

Press Mentions

Photobiomodulation for Early Dry AMD Gets Enthusiastic ReceptionJuly 23rd, 2024